ArticleNeurogenetics2026
Spastic paraparesis linked to a rare presenilin-1 mutation.
Article in Neurogenetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Familial Alzheimer's disease (FAD) accounts for < 1% of AD cases and is mainly associated with pathogenic variations in presenilin 1 (PSEN1), PSEN2 and the amyloid precursor protein [1]. Most patients present with an earlier onset classic amnestic syndrome [2]. We report a 37-year-old female with progressive spastic paraparesis (SP), wheelchair-dependent at 40-years-old and bedridden at 43yo. She developed mild cognitive complaints at 41yo. Multigene panel revealed a rare probably pathogenic heterozygous PSEN1 variant (p.Pro433Ser). CSF was consistent with pathological Alzheimer continuum. This highlights the importance of considering AD in SP of undetermined cause, showing a novel clinical association between PSEN1 p.Pro433Ser and SP.
Indexed as
Identifiers
42113316What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.